Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.024
Buy
RSI(14)
53.227
Neutral
STOCH(KDJ)(9,3,3)
72.738
Neutral
ATR(14)
0.345
Low Volatility
CCI(14)
57.490
Neutral
Williams %R
27.350
Buy
TRIX(12,20)
-0.109
Sell
StochRSI(14)
55.451
Sell
Search
Sight Sciences Inc
SGHTAdd to Watchlist
5.260USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
286.20MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+7.13%
1 Month
-3.31%
6 Months
-18.32%
Year to Date
-33.67%
1 Year
+60.86%
Key Figures
5.260Open
5.310High
95.83KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.18%Turnover Ratio
5.260Prev. Close
5.100Low
353.26KTurnover
LossP/E Static
5.27P/B
0.00%Div Yield TTM
-31.12%ROA
9.23652wk High
0.92Volume Ratio
-51.51MNet Profit
54.03MShares
-0.7015EPS TTM
2.42Beta
-56.64%ROE
3.11052wk Low
3.99%Amplitude
86.19%Gross Margin
286.20MMarket Cap
-0.94Reward/Risk
4.29%Risk Rate
TradingKey Stock Score of Sight Sciences Inc
Currency: USD Updated: 2026-07-31Key Insights
Sight Sciences Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 99 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.33.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sight Sciences Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Sight Sciences Inc Highlights
StrengthsRisks
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Growing
The company is in a growing phase, with the latest annual income totaling USD 77.36M.
Undervalued
The company’s latest PE is -7.50, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 27.85M shares, increasing 3.28% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 89.47K shares of this stock.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
8.333
Target Price
+58.43%
Upside Space
Sight Sciences Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
8
analysts
Buy
Current Rating
8.333
Target Price
+58.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Sight Sciences Inc
SGHT
8
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
5.256
Buy
MA10
5.087
Buy
MA20
5.175
Buy
MA50
5.092
Buy
MA100
4.600
Buy
MA200
5.538
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Sight Sciences Inc Info
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Ticker SymbolSGHT
CompanySight Sciences Inc
CEOBadawi (Paul)
Websitehttps://www.sightsciences.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52667.700
+289.700 (+0.55%)
28461.200
+300.300 (+1.07%)
7521.500
+46.400 (+0.62%)
14782.000
+33.000 (+0.22%)
63480.000
+628.000 (+1.00%)
6392.800
+27.400 (+0.43%)
79.740
-6.194 (-7.21%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4068.770
+27.340 (+0.68%)
FAQs
What is the current price of Sight Sciences Inc (SGHT)?
The current price of Sight Sciences Inc (SGHT) is 5.26.
What is the symbol of Sight Sciences Inc?
The ticker symbol of Sight Sciences Inc is SGHT.
What is the 52-week high of Sight Sciences Inc?
The 52-week high of Sight Sciences Inc is 9.24.
What is the 52-week low of Sight Sciences Inc?
The 52-week low of Sight Sciences Inc is 3.11.
What is the market capitalization of Sight Sciences Inc?
The market capitalization of Sight Sciences Inc is 284.22M.
Is Sight Sciences Inc (SGHT) currently rated as Buy, Hold, or Sell?
According to analysts, Sight Sciences Inc (SGHT) has an overall rating of Buy, with a price target of 8.33.
What is the Earnings Per Share (EPS TTM) of Sight Sciences Inc (SGHT)?
The Earnings Per Share (EPS TTM) of Sight Sciences Inc (SGHT) is -0.74.